Daniel Newman Mendelson - Net Worth and Insider Trading

Daniel Newman Mendelson Net Worth

The estimated net worth of Daniel Newman Mendelson is at least $959,359 dollars as of 2024-05-10. Daniel Newman Mendelson is the Director of Champions Oncology Inc and owns about 198,625 shares of Champions Oncology Inc (CSBR) stock worth over $959,359. Details can be seen in Daniel Newman Mendelson's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Daniel Newman Mendelson has not made any transactions after 2024-01-12 and currently still holds the listed stock(s).

Transaction Summary of Daniel Newman Mendelson

To

Daniel Newman Mendelson Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Daniel Newman Mendelson owns 3 companies in total, including Champions Oncology Inc (CSBR) , HMS Holdings Corp (HMSY) , and PharMerica Corp (PMC) .

Click here to see the complete history of Daniel Newman Mendelson’s form 4 insider trades.

Insider Ownership Summary of Daniel Newman Mendelson

Ticker Comapny Transaction Date Type of Owner
CSBR Champions Oncology Inc 2024-01-12 director
HMSY HMS Holdings Corp 2014-11-12 director
PMC PharMerica Corp 2010-05-26 director

Daniel Newman Mendelson Latest Holdings Summary

Daniel Newman Mendelson currently owns a total of 1 stock. Daniel Newman Mendelson owns 198,625 shares of Champions Oncology Inc (CSBR) as of January 12, 2024, with a value of $959,359.

Latest Holdings of Daniel Newman Mendelson

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
CSBR Champions Oncology Inc 2024-01-12 198,625 4.83 959,359

Holding Weightings of Daniel Newman Mendelson


Daniel Newman Mendelson Form 4 Trading Tracker

According to the SEC Form 4 filings, Daniel Newman Mendelson has made a total of 27 transactions in Champions Oncology Inc (CSBR) over the past 5 years, including 27 buys and 0 sells. The most-recent trade in Champions Oncology Inc is the acquisition of 1,000 shares on January 12, 2024, which cost Daniel Newman Mendelson around $6,500.

Insider Trading History of Daniel Newman Mendelson

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Daniel Newman Mendelson Trading Performance

GuruFocus tracks the stock performance after each of Daniel Newman Mendelson's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Daniel Newman Mendelson is -4.41%. GuruFocus also compares Daniel Newman Mendelson's trading performance to market benchmark return within the same time period. The performance of stocks bought by Daniel Newman Mendelson within 3 months outperforms 3 times out of 27 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Daniel Newman Mendelson's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Daniel Newman Mendelson

Average Return

Average return per transaction

Outperforming Transactions

2 out of 2 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 6.06
Relative Return to S&P 500(%) 3.99

Daniel Newman Mendelson Ownership Network

Ownership Network List of Daniel Newman Mendelson

No Data

Ownership Network Relation of Daniel Newman Mendelson


Daniel Newman Mendelson Owned Company Details

What does Champions Oncology Inc do?

Who are the key executives at Champions Oncology Inc?

Daniel Newman Mendelson is the director of Champions Oncology Inc. Other key executives at Champions Oncology Inc include director & President Ronnie Morris , 10 percent owner New Enterprise Associates 14, L.p. , and 10 percent owner Roger H Lee .

Champions Oncology Inc (CSBR) Insider Trades Summary

Over the past 18 months, Daniel Newman Mendelson made 25 insider transaction in Champions Oncology Inc (CSBR) with a net purchase of 75,504. Other recent insider transactions involving Champions Oncology Inc (CSBR) include a net purchase of 12,382 shares made by Ronnie Morris ,

In summary, during the past 3 months, insiders sold 0 shares of Champions Oncology Inc (CSBR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Champions Oncology Inc (CSBR) were sold and 87,886 shares were bought by its insiders, resulting in a net purchase of 87,886 shares.

Champions Oncology Inc (CSBR)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Champions Oncology Inc Insider Transactions

No Available Data

Daniel Newman Mendelson Mailing Address

Above is the net worth, insider trading, and ownership report for Daniel Newman Mendelson. You might contact Daniel Newman Mendelson via mailing address: Coventry Health Care, Inc., 6705 Rockledge Dr, Suite 900, Bethesda Md 20817.

Discussions on Daniel Newman Mendelson

No discussions yet.